Search Results for “vaccine” – Page 24 – media

Tuberculosis Vaccine (BCG) Can Treat Type 1 Diabetes

Administration of two doses of BCG with a duration of four weeks apart can normalize the blood sugar levels for up to eight years. Tumor necrosis factor (TNF) is a protein that eliminates improper immune cells that destroy pancreatic islets, involved in immune production. But the administration of BCG can ultimately regulate T cells and boost TNF production.
- Source: FierceBiotech
- 602
- June 25, 2018
diabetes Researches tuberculosis
Imutex Universal FLU Vaccine Reaching Phase 3

In phase 2b clinical trial work, FLU-v met its goal of boosting T-cell immune response at 42 days and 180 days after vaccination. The infection rate came down by meeting a secondary endpoint of boosting antibodies in vaccinated patients. Thus, this single adjuvant dose is considered as the "most immunological and efficient."
- Source: FiercePharma
- 887
- June 21, 2018
Clinical Trials flu influenza vaccine
Viagra and Flu Vaccine Prevents Cancer Regrowth

A research team from the University of Ottawa in Canada revealed a safe and inexpensive treatment by employing Viagra and flu vaccines that might stop cancer revival. Tadalafil (Cialis), sildenafil (Viagra) in combination with Agriflu were used in the research work.
- Source: Ddu
- 715
- May 31, 2018
cancer Clinical Trials flu
Discovery of Novel Single Shot Nano Polio Vaccine

A research team from MIT’s Koch Institute for Integrative Cancer Research in Cambridge, US discovered a novel one-shot nano polio vaccine to eradicate polio. The inactivated polio vaccine was encapsulated in a biodegradable polymer named as PLGA.
- Source: Ddu
- 614
- May 28, 2018
polio Researches vaccines
Experimental Merck vaccine gears up to fight Congo Ebola outbreak

As the Democratic Republic of Congo deals with a rising death toll owing to the latest outbreak of Ebola, health officials are moving fast to counter the fatal effects of the deadly virus. Plans are afoot to implement the experimental vaccine developed by Merck & Co to confront the overwhelming challenges posed by the virus.
- Source: Ddu
- 720
- May 15, 2018
Ebola Merck New Approvals vaccines
Personalized Cancer Vaccine Looks Promising in Early Study

Researchers at the Perelman School of Medicine and the Abramson Cancer Center, at the University of Pennsylvania, developed the vaccine using dendritic cells (DCs) derived from each patient's own peripheral blood mononuclear cells. These dendritic cells were then exposed to the patient's tumor cells, activated with interferon gamma, and injected into the patient's lymph nodes.
- Source: Clinical Advisor
- 648
- May 15, 2018
anti-cancer cancer Researches
Moderna and Merck Expand mRNA Cancer Vaccines Collaboration

Expansion Includes the Joint Development of Moderna’s KRAS Oncogene Program and Other Potential mRNA Cancer Vaccines; Merck to Make Equity Investment in Moderna
- Source: investors.merck
- 526
- May 7, 2018
Merck mRNA cancer vaccines
Manufacturing hiccup in China trips up Sanofi’s vaccine sales momentum

After a strong 2017, Sanofi Pasteur got off to a less-than-stellar start this year. In China, inspectors put a temporary kibosh on imports of the pediatric shot Pentaxim, thanks to vaccine batches that failed to pass inspection. That move hobbled the shot's sales—and dragged the rest of the unit down, too.
- Source: fiercepharma
- 630
- May 2, 2018
Company Insights Pentaxim Sanofi
Specialty Vaccines for Overlooked Infectious Diseases–Challenges and Opportunities

Developing specialty vaccines for emerging and overlooked infectious diseases is a challenging and rewarding enterprise with specific opportunities and problems. Large companies have not historically prioritized this area and instead have focused on the development and commercialization of routine vaccines and vaccines for diseases with more significant global markets.
- Source: fiercepharma
- 480
- April 28, 2018
Researches vaccines
First step in development of pill-based vaccines

Researchers from Cardiff University have created the world’s first synthetic, non-biologic vaccine.
- Source: cardiff.ac.uk
- 494
- March 16, 2018
influenza vaccine non-biologic Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.